Incretin Atlas › Trials › REIMAGINE 1 (early T2D)
REIMAGINE 1 (early T2D)
CagriSema · t2d
Design
- Molecule(s)
- CagriSema
- Population
- t2d
- Official title
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
- Sponsor
- Novo Nordisk A/S
- Phase
- 3
- Registry status
- completed · 2024-03 → 2025-10
- Participants
- 189
- Duration
- 40 weeks
- Registry
- NCT06323174
Results by arm
| Arm | Population | Weeks | n | Weight, efficacy | Weight, treatment-policy | HbA1c, pp | AE discontinuation, % | Any discontinuation, % | Nausea, % | Vomiting, % | SAE, % | SBP, mmHg | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CagriSema 2.4/2.4 mg | t2d | 40 | 189 | −14.3 % vs −2.8 % Δ −11.5 pp | −14.3 % vs −2.8 % Δ −11.5 pp | — | — | — | — | — | — | — | verified |
Weight: percent change from baseline, drug vs placebo or comparator, Δ = difference in percentage points. Efficacy estimand = effect while on treatment (hypothetical strategy); treatment-policy = all randomised participants regardless of adherence (ITT). AE discontinuation = stopped study drug for any adverse event. Hover a status for its definition.
Verbatim quotes from the source (1)
- CagriSema 2.4/2.4 mg · weight_eff · Results, MRI sub-study
CagriSema reduced BW vs pbo (2.4 mg/2.4 mg: −14.3%; 1.0 mg/1.0 mg: −11.2%; pbo: −2.8%;
Primary sources
- Jøran Hjelmesæth et al. Efficacy of CagriSema on body composition in participants with early type 2 diabetes: REIMAGINE 1. Abstract LBA 11. EASD 2026 Annual Meeting; 2026 Sep 29–Oct 3; Milan. [Session: LBA OP 02 New and old drugs: reproductive or metabolic relevance]
- ClinicalTrials.gov NCT06323174
How to cite this page
Medical Adviser's Group. Incretin Atlas: REIMAGINE 1 (early T2D). Data cut 12 November 2026. https://docs.mdwrt.app/infographics/incretin-atlas/trials/reimagine-1/ Data: doi:10.5281/zenodo.23473913. Accessed 16 November 2026.
Cite the primary publication for any single result; every value above links to it.